MENU
+Compare
GNFT
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$4.14
Change
+$0.16 (+4.02%)
Capitalization
208.16M

GNFT Genfit SA Forecast, Technical & Fundamental Analysis

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology... Show more

Industry: #Biotechnology
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GNFT with price predictions
Jul 25, 2025

GNFT's RSI Indicator recovers from oversold territory

The RSI Oscillator for GNFT moved out of oversold territory on June 26, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In of the 23 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 21, 2025. You may want to consider a long position or call options on GNFT as a result. In of 118 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GNFT just turned positive on July 14, 2025. Looking at past instances where GNFT's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

GNFT moved above its 50-day moving average on July 25, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNFT advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for GNFT crossed bearishly below the 50-day moving average on June 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNFT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GNFT broke above its upper Bollinger Band on July 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GNFT entered a downward trend on July 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GNFT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.540) is normal, around the industry mean (18.028). P/E Ratio (117.216) is within average values for comparable stocks, (59.593). GNFT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (2.621) is also within normal values, averaging (278.844).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNFT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GNFT is expected to report earnings to fall 126.20% to 11 cents per share on September 22

Genfit SA GNFT Stock Earnings Reports
Q2'25
Est.
$0.11
Q4'24
Beat
by $0.02
Q2'24
Beat
by $0.25
The last earnings report on April 24 showed earnings per share of -43 cents, beating the estimate of -45 cents. With 850.00 shares outstanding, the current market capitalization sits at 208.16M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Parc Eurasante
Phone
+33 320164000
Employees
148
Web
https://www.genfit.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPIRF8.00N/A
N/A
Piraeus Financial Holdings S.A.
HGHAF0.62N/A
N/A
HIGH ARCTIC ENERGY SVCS INC NEW
LKHLY12.88N/A
N/A
Lonking Holdings, Ltd.
SDVKF24.72N/A
N/A
Sandvik AB
HNWEF0.07N/A
N/A
PEAK DISCOVERY CAP LTD.

GNFT and Stocks

Correlation & Price change

A.I.dvisor tells us that GNFT and BCDA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNFT and BCDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
+3.99%
BCDA - GNFT
26%
Poorly correlated
+1.73%
QURE - GNFT
24%
Poorly correlated
-0.66%
FENC - GNFT
24%
Poorly correlated
-1.03%
GUTS - GNFT
23%
Poorly correlated
+0.52%
GLPG - GNFT
23%
Poorly correlated
+5.83%
More